New Improved Pathway for Parasitic Infection Therapeutics
Trojan Horse Drug Delivery for Treatment of Parasitic Infections
Tags: Australian National University, Australia, Healthcare & Lifesciences, Agriculture & Food
ANU has innovated a drug-lipid conjugate targeting parasitic lipid uptake mechanisms, offering a novel approach to combating diseases like malaria and toxoplasmosis. This method allows for lower dosages and has shown high efficacy in both disease-causing and transmissible stages of parasites. It represents a significant advance in anti-parasitic drug delivery, potentially transforming treatments in agriculture, veterinary science, and human health. The technology opens new pathways in parasitic infection therapeutics, improving existing drug efficacy.
IP Type or Form Factor: Patent Pending; Platform; Process & Method
TRL: 4 - minimum viable product built in lab
Industry or Tech Area: Pharmaceutical Engineering; Agriculture
